Appointment to the Clinical Advisory Board

RNS Number : 7059P
Surgical Innovations Group PLC
04 October 2013



Surgical Innovations Group plc

("SI" or the "Group" or the "Company")


Appointment to the Clinical Advisory Board


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of veterinary surgeon Romain Pizzi to its Clinical Advisory Board ('CAB') with immediate effect.


Romain Pizzi, BVsc, Msc, DZooMed, MACVSc (Surg), FRES, FRGS, MRCVS, is the only veterinary surgeon in the UK to specialise in minimally invasive keyhole surgery for wildlife and has had strong links with SI for many years helping drive awareness of Surgical's MIS products. Romain has previously worked in veterinary private practice, academia, and numerous charities and NGOs developing MIS in domestic and exotic animal species since 2006. Romain was the first vet to ever perform keyhole surgery on a reindeer at Edinburgh Zoo in 2009, using surgical instruments donated by SI. He is a veterinary surgeon at the Royal Zoological Society of Scotland, Edinburgh Zoo, as well as at the Scottish SPCA's (Society for the prevention of Cruelty to Animals) National Wildlife Rescue Centre, and is a Special Lecturer in Zoo and Wildlife Medicine at the University of Nottingham.


Romain brings with him great knowledge of the Company's laparoscopic devices, especially the innovative 3mm instruments, having performed over 600 keyhole MIS procedures on zoo and wild animals. He is a talented natural speaker and communicator having presented for the BBC and Discovery's Animal Planet channel, and spoken at several UK surgical conferences where he has passed on his understanding of SI's MIS instruments to other surgeons working in human healthcare. Romain will provide SI with substantial PR opportunities moving forward.


Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "We are delighted to bring Romain to the CAB, having had strong links with him for many years this seems an appropriate move forward. Romain can bring his wealth of knowledge of MIS instruments from the veterinary world to surgeons working in human healthcare and will be a great ambassador for the Company. Having Romain on the CAB will strengthen the profile of SI's instruments and will help further develop our innovative to their particular needs."






Surgical Innovations Group plc

Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer



Panmure Gordon (Nominated Advisor & Broker)

Fred Walsh/ Freddy Crossley (Corporate Finance)

Tel: +44 (0) 20 7886 2500

Adam Pollock/ Victoria Boxall (Corporate Broking)




Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303






Notes to Editors:


About Surgical Innovations Group plc


Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 


For more information, see


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings